{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:25Z","timestamp":1792799425588,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ebiom.2023.104922","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T16:01:07Z","timestamp":1703088067000},"page":"104922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1849-8874","authenticated-orcid":false,"given":"Alix","family":"Miauton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gine","family":"Audran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maby-El Hajjami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Karlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loane","family":"Warpelin-Decrausaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Sene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Schaufelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Faouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Anne","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Spertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Genton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7446","key":"10.1016\/j.ebiom.2023.104922_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2023.104922_bib2","series-title":"Fact sheets: dengue and severe dengue","year":"2017"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104922_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007213","article-title":"Global expansion and redistribution of Aedes-borne virus transmission risk with climate change","volume":"13","author":"Ryan","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2023.104922_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100712","article-title":"Global, regional, and national dengue burden from 1990 to 2017: a systematic analysis based on the global burden of disease study 2017","volume":"32","author":"Zeng","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ebiom.2023.104922_bib5","series-title":"Ten threats to Global Health in 2019","year":"2019"},{"key":"10.1016\/j.ebiom.2023.104922_bib6","series-title":"Global strategy for dengue prevention and control 2012-2020","first-page":"35","year":"2012"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104922_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6365","key":"10.1016\/j.ebiom.2023.104922_bib8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104922_bib9","first-page":"17","article-title":"Dengue vaccine safety update","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"issue":"7936","key":"10.1016\/j.ebiom.2023.104922_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/d41586-022-03546-2","article-title":"Dengue vaccine poised for roll-out but safety concerns linger","volume":"611","author":"Mallapaty","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104922_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/ciac690","article-title":"Safety of dengue vaccine?","volume":"76","author":"de Silva","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104922_bib12","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice","volume":"193","author":"Zellweger","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104922_bib13","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00036-15","article-title":"CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice","volume":"89","author":"Zellweger","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2023.104922_bib14","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3389\/fimmu.2019.02125","article-title":"Human T cell response to dengue virus infection","volume":"10","author":"Tian","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104922_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030700","article-title":"Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? There is only one true winner","volume":"10","author":"Halstead","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104922_bib16","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1038\/s41467-019-11634-7","article-title":"Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling","volume":"10","author":"Waickman","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104922_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/14760584.2020.1758070","article-title":"Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases","volume":"19","author":"Dykman","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104922_bib18","first-page":"42","article-title":"Anatomy of a \u2018correlate of protection\u2019for T-cell vaccines","volume":"27","author":"Rademacher","year":"2022","journal-title":"Eur Pharm Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104922_bib19","article-title":"Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes","volume":"2","author":"Tatovic","year":"2022","journal-title":"Immunother Adv"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104922_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/jir814","article-title":"Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response","volume":"205","author":"Testa","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"6205","key":"10.1016\/j.ebiom.2023.104922_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1254536","article-title":"T\u00a0cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses","volume":"346","author":"Schenkel","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104922_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/vaccines7010010","article-title":"Time to micromanage the pathogen-host-vector interface: considerations for vaccine development","volume":"7","author":"Manning","year":"2019","journal-title":"Vaccines"},{"issue":"278","key":"10.1016\/j.ebiom.2023.104922_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0526","article-title":"Virus-specific T lymphocytes home to the skin during natural dengue infection","volume":"7","author":"Rivino","year":"2015","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104922_bib24","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104922_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/vaccines6030050","article-title":"Activation-induced markers detect vaccine-specific CD4\u207a T cell responses not measured by assays conventionally used in clinical trials","volume":"6","author":"Bowyer","year":"2018","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104922_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imm.12499","article-title":"More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers","volume":"146","author":"Dolton","year":"2015","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104922_bib27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1473-3099(14)70811-4","article-title":"Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study","volume":"14","author":"Osorio","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"27","key":"10.1016\/j.ebiom.2023.104922_bib28","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/j.vaccine.2018.05.028","article-title":"A\u00a0phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104922_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A\u00a0novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104922_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fimmu.2020.00479","article-title":"Rapid induction and maintenance of virus-specific CD8(+) T(EMRA) and CD4(+) T(EM) cells following protective vaccination against dengue virus challenge in humans","volume":"11","author":"Graham","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104922_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.immuni.2015.02.009","article-title":"CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells","volume":"42","author":"Hickman","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104922_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nm.3105","article-title":"Persistent antigen at vaccination sites induces tumor-specific CD8\u207a T cell sequestration, dysfunction and deletion","volume":"19","author":"Hailemichael","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2023.104922_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703887","article-title":"Adapting rapid diagnostic tests to detect historical dengue virus infections","volume":"12","author":"Echegaray","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104922_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cell.2015.03.031","article-title":"Quantifying memory CD8 T cells reveals regionalization of immunosurveillance","volume":"161","author":"Steinert","year":"2015","journal-title":"Cell"},{"issue":"36","key":"10.1016\/j.ebiom.2023.104922_bib35","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1016\/j.vaccine.2017.07.045","article-title":"Immune correlates of protection for dengue: state of the art and research agenda","volume":"35","author":"Katzelnick","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104922_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/JVI.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J\u00a0Virol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423004887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423004887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T21:10:41Z","timestamp":1739481041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423004887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":36,"alternative-id":["S2352396423004887"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104922","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104922"}}